04:12 PM EDT, 09/30/2025 (MT Newswires) -- Michael Cloonan, Director, President & CEO, on September 26, 2025, sold 25,000 shares in Sionna Therapeutics ( SION ) for $727,798. Following the Form 4 filing with the SEC, Cloonan has control over a total of 547,343 common shares of the company, with 547,343 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2036042/000170433625000004/xslF345X05/edgardoc.xml ...

03:46 PM EDT, 09/29/2025 (MT Newswires) -- Cosmos Health ( COSM ) said Monday it plans to expand its international presence and scale its branded product and pharmaceutical portfolio, while increasing its investments in blockchain and artificial intelligence, as the company targets to become a global powerhouse by 2030. Cosmos began implementing a $300 million financing facility secured in August,...

Sept 29 (Reuters) - CSX Corp ( CSX ) on Monday has appointed Steve Angel as its top boss, replacing Joe Hinrichs, as the railroad operator fends off pressure from an activist investor while facing industry consolidation. Shares of the company rose about 3% in premarket trade. Angel succeeds Joe Hinrichs, who will work closely with the board and management...

NEW YORK, Sept. 29, 2025 /PRNewswire/ -- FutureCrest Acquisition Corp. (the Company) announced today the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the exercise in full by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $287,500,000. The Company's units began...